DEFINITIVE CONTRACT
Active75F40126C00081
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$749.8K
obligated · signed 2 months ago
EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP1 VALID APPROACHES TO INTEGRATING PATIENT SCIENCE INTO MEDICAL DEVICE STUDIES
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2029
with all options
Loading status
Estimated start: Sep 29, 2028
DUKE UNIVERSITY
Contract 75F40126C00081
UEI
TP7EK8DZV6N5
Parent Company
DUKE UNIVERSITY
Capabilities & Certifications
Headquarters Location
Congressional District: 04
Current Obligation
$749,762
Base + Exercised Options
$749,762
Total Ceiling Value
$749,762
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.